Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Biofilms are microbial communities, embedded in a polymeric matrix, growing attached to a surface. Nearly all device-associated infections involve growth in the biofilm life style. Biofilm communities have characteristic architecture and distinct phenotypic properties. The most clinically important phenotype involves extraordinary resistance to antimicrobial therapy, making biofilm infections very difficulty to cure without device removal. The current studies examine drug resistance in Candida albicans biofilms. Similar to previous reports, we observed marked fluconazole and amphotericin B resistance in a C. albicans biofilm both in vitro and in vivo. We identified biofilm-associated cell wall architectural changes and increased β-1,3 glucan content in C. albicans cell walls from a biofilm compared to planktonic organisms. Elevated β-1,3 glucan levels were also found in the surrounding biofilm milieu and as part of the matrix both from in vitro and in vivo biofilm models. We thus investigated the possible contribution of β-glucans to antimicrobial resistance in Candida albicans biofilms. Initial studies examined the ability of cell wall and cell supernatant from biofilm and planktonic C. albicans to bind fluconazole. The cell walls from both environmental conditions bound fluconazole; however, four- to fivefold more compound was bound to the biofilm cell walls. Culture supernatant from the biofilm, but not planktonic cells, bound a measurable amount of this antifungal agent. We next investigated the effect of enzymatic modification of β-1,3 glucans on biofilm cell viability and the susceptibility of biofilm cells to fluconazole and amphotericin B. We observed a dose-dependent killing of in vitro biofilm cells in the presence of three different β-glucanase preparations. These same concentrations had no impact on planktonic cell viability. β-1,3 Glucanase markedly enhanced the activity of both fluconazole and amphotericin B. These observations were corroborated with an in vivo biofilm model. Exogenous biofilm matrix and commercial β-1,3 glucan reduced the activity of fluconazole against planktonic C. albicans in vitro. In sum, the current investigation identified glucan changes associated with C. albicans biofilm cells, demonstrated preferential binding of these biofilm cell components to antifungals, and showed a positive impact of the modification of biofilm β-1,3 glucans on drug susceptibility. These results provide indirect evidence suggesting a role for glucans in biofilm resistance and present a strong rationale for further molecular dissection of this resistance mechanism to identify new drug targets to treat biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, although β-1,3-glucans contribute to drug resistance and are the major cell wall polysaccharide (130), we now know that they constitute only a small fraction of the total polysaccharides present, implying that the matrix is not constructed simply of released cell wall constituents.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One known constituent of the biofilm matrix that contributes to its drug-resistance properties is the polysaccharide β-1,3-glucan (130).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Few studies have shown that fluconazole-resistant (FR) C. albicans may also exhibit higher levels of β-glucans compared to susceptible strains (12, 16).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher levels of β-glucans absorb fluconazole and inhibit its penetration to the site of action (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-glucans can act as a physical barrier, reducing the accessibility of fluconazole to its target sites in the cell membrane and limiting its effectiveness (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269 · cited 1×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described (18, 22 , 40).”
MethodBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17 , 20, 21, 24, 41, 46, 50).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20 , 21, 24, 41, 46, 50).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921 · cited 2×
“Previous studies in a bacterial biofilm model demonstrated sequestration of antimicrobial compounds by a cell wall component, specifically, the -1,3 glucan component of biofilm cells (33, 34 ).”
BackgroundMethods in yeast genetics : a Cold Spring Harbor Laboratory course manual
Amberg, D. C., Burke, D. J., & Strathern, J. N. (2005) · Cited by 1,803
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 3×
“C. albicans is a major human pathogen which can grow as a biofilm and inhabit the surface of many medical devices (28, 44 ).”
BackgroundInfluentialClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“A number of molecular mechanisms have been implicated in nonbiofilm antifungal resistance in C. albicans ( 54 ).”
BackgroundA genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans ( 21 , 28, 45, 46).”
BackgroundCandida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans (21, 28 , 45, 46).”
BackgroundReference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753 · cited 1×
“Most times, an implanted device, such as an intravascular catheter, is associated with biofilm infections ( 48 ).”
BackgroundCell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression
Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D., & Martínez, J. P. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.130-180.1998 · Cited by 726 · cited 1×
“The cell walls of fungi, plants, and bacteria provide a number of essential functions, including acting as a permeability barrier, providing cell shape, and interacting with host cells ( 14 , 29, 35).”
BackgroundRamage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans (21, 28, 45, 46 ).”
BackgroundOstrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
Architecture of the Yeast Cell Wall
Kollár, R., Reinhold, B. B., Petráková, E., Yeh, H. J. C., Ashwell, G., Drgonová, J., Kapteyn, J. C., Klis, F. M., & Cabib, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17762 · Cited by 644
Biofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20, 21, 24 , 41, 46, 50).”
BackgroundForging a Link Between Biofilms and Disease
Potera, C. (1999) · Science · doi:10.1126/science.283.5409.1837 · Cited by 548 · cited 1×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans (21, 28, 45 , 46).”
BackgroundAl-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundMukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511 · cited 3×
“However, sterol changes have been associated with mature (late) biofilm growth and have been hypothesized to contribute to biofilm drug resistance ( 37 ).”
BackgroundInfluentialRamage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundResistance of Candida albicans biofilms to antifungal agents in vitro
Hawser, S. P., & Douglas, L. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2128 · Cited by 406 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundBaillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389 · cited 3×
“Finally, a number of studies have experimentally addressed the contribution of the extracellular matrix in modulating biofilm cell susceptibility (2, 10 , 26, 36).”
BackgroundInfluentialAndes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundSelf-citationGlobal Control of Dimorphism and Virulence in Fungi
Nemecek, J. C., Wüthrich, M., & Klein, B. S. (2006) · Science · doi:10.1126/science.1124105 · Cited by 376 · cited 2×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described (18, 22, 40 ).”
MethodCharacteristics of biofilm formation by Candida albicans.
Ramage, G., VandeWalle, K., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 376
Ramage, G., VandeWalle, K., Bachmann, S. P., Wickes, B. L., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3634-3636.2002 · Cited by 244
Dallies, N., François, J., & Paquet, V. (1998) · Yeast · doi:10.1002/(sici)1097-0061(1998100)14:14<1297::aid-yea310>3.0.co;2-l · Cited by 236 · cited 3×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described ( 18 , 22, 40).”
MethodInfluentialPenetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235 · cited 2×
“-1,3 Glucan was measured in serum using the Fungitell (1, 3 )--D-glucan detection reagent kit (Associates of Cape Cod) per the manufacturer’s directions (43).”
MethodEffect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundCandida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20, 21, 24, 41 , 46, 50).”
BackgroundSelf-citationMunro, C. A., Bates, S., Buurman, E. T., Hughes, H. B., MacCallum, D. M., Bertram, G., Atrih, A., Ferguson, M. A. J., Bain, J. M., Brand, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411413200 · Cited by 200
Comprehensive Proteomic Analysis of Saccharomyces cerevisiae Cell Walls
Yin, Q. Y., de Groot, P. W. J., Dekker, H. L., de Jong, L., Klis, F. M., & de Koster, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500334200 · Cited by 199
Production of extracellular matrix by Candida albicans biofilms
Hawser, S. P., Baillie, G. S., & Douglas, L. J. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-3-253 · Cited by 183 · cited 2×
“Previous work by Douglas and colleagues demonstrated secreted carbohydrate differences between biofilm and planktonic cells (2, 10, 26 ).”
BackgroundCandida biofilms: antifungal resistance and emerging therapeutic options.
Kuhn, D. M., & Ghannoum, M. A. (2004) · PubMed · Cited by 170
Masuoka, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.281-310.2004 · Cited by 166 · cited 1×
“The cell walls of fungi, plants, and bacteria provide a number of essential functions, including acting as a permeability barrier, providing cell shape, and interacting with host cells (14, 29, 35 ).”
Background[48] Candida biofilms and their susceptibility to antifungal agents
Baillie, G. S., & Douglas, L. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10050-8 · Cited by 161 · cited 1×
“Candida biofilms have been shown to be resistant to antifungals, including amphotericin B, triazoles, and flucytosine ( 12 , 15, 25, 30, 31).”
BackgroundShimoi, H., Kitagaki, H., Ohmori, H., Iimura, Y., & Ito, K. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.13.3381-3387.1998 · Cited by 154
Magnelli, P. E., Cipollo, J. F., & Abeijón, C. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5473 · Cited by 144
Extracellular Polymer of Candida albicans: Isolation, Analysis and Role in Adhesion
McCourtie, J., & Douglas, L. (1985) · Microbiology · doi:10.1099/00221287-131-3-495 · Cited by 142 · cited 2×
“Finally, a number of studies have experimentally addressed the contribution of the extracellular matrix in modulating biofilm cell susceptibility (2, 10, 26, 36 ).”
BackgroundMethodLewis, R. E., Kontoyiannis, D. P., Darouiche, R. O., RAAD, I. I., & Prince, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3499-3505.2002 · Cited by 105
Cassone, A., Kerridge, D., & Gale, E. F. (1979) · Journal of General Microbiology · doi:10.1099/00221287-110-2-339 · Cited by 100 · cited 1×
“In the 1970s, studies suggested that glucan changes associated with the stationary phase of growth in C. albicans were responsible for reduced susceptibility to the polyene amphotericin B ( 13 , 23).”
BackgroundIron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B
Baillie, G. S., & Douglas, L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2146 · Cited by 95 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundHerrero, A. B., Magnelli, P. E., Mansour, M. K., Levitz, S. M., Bussey, H., & Abeijón, C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1423-1432.2004 · Cited by 91 · cited 1×
“Washed cells were broken with glass beads, and cell walls were isolated as previously described (18, 19, 27 , 32, 55).”
MethodOdds, F. C., Nuffel, L. V., & Gow, N. A. R. (2000) · Microbiology · doi:10.1099/00221287-146-8-1881 · Cited by 80 · cited 1×
“We used viable kidney counts as an estimate of total body Candida burden, since it is widely accepted as the most significantly impacted end organ in disseminated models (7, 42 ).”
MethodAketagawa, J., Tanaka, S., Tamura, H., Shibata, Y., & Saitô, H. (1993) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124103 · Cited by 79
Purified Horseshoe Crab Factor G
Muta, T., Seki, N., Takaki, Y., Hashimoto, R., Oda, T., Iwanaga, A., Tokunaga, F., & Iwanaga, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.892 · Cited by 79
Reeves, D. S. (1999) · Cited by 65
Dorsthorst, D. T. A. T., Verweij, P. E., Meis, J. F. G. M., Punt, N. C., & Mouton, J. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2007-2013.2004 · Cited by 37 · cited 1×
“The impact of the compounds in combination was assessed using the fractional inhibitory concentration (FIC) index {FIC index [(ED50 or ED80 of drug A in combination)/ (ED50 or ED80 of drug A alone)] [(ED50 or ED80 of drug B in combination)/ (ED50 or ED80 drug B alone)]; values below 0.5 are suggestive of an enhanced i…”
MethodInfluentialAngiolella, L., Micocci, M. M., D'Alessio, S., Girolamo, A., Maras, B., & Cassone, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1688-1694.2002 · Cited by 34
Gale, E. F., Ingram, J., Kerridge, D., Notario, V., & Wayman, F. J. (1980) · Microbiology · doi:10.1099/00221287-117-2-383 · Cited by 33 · cited 1×
“In the 1970s, studies suggested that glucan changes associated with the stationary phase of growth in C. albicans were responsible for reduced susceptibility to the polyene amphotericin B (13, 23 ).”
BackgroundUse of an Animal Model of Disseminated Candidiasis in the Evaluation of Antifungal Therapy
Andes, D. R. (2005) · Humana Press eBooks · doi:10.1385/1-59259-943-5:111 · Cited by 32 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundSelf-citationANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.1-21.2006 · Cited by 11
Miosga, T., & Zimmermann, F. K. (1996) · Yeast · doi:10.1002/(sici)1097-0061(19960615)12:7<653::aid-yea953>3.0.co;2-t · Cited by 8
Research works printed but not linked: 1
- 10.1002/(sici)1097-0061(19960615)12:7<683::aid-yea959>3.0.co;2-8 · DOI
Cited by
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
“The primary component of biofilm matrix is b-glucan (Finkel & Mitchell, 2011; Nett et al., 2007).”
BackgroundCandida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
Metadata
- Authors
- Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D.
- Affiliations
- University of Wisconsin–Madison (US)
- Departments of Medicine and Medical Microbiology and Immunology
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 51
- Issue
- 2
- Pages
- 510-520
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1797745
- OpenAlex
- W1999751604
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 22 · 2022: 20 · 2021: 15 · 2020: 26 · 2019: 19 · 2018: 22 · 2017: 34 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 20 · 2012: 23
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, β-1,3-glucan, antifungal resistance, fluconazole resistance, amphotericin B resistance, β-glucanase, cell wall architecture, biofilm matrix, planktonic versus biofilm cells, device-related infection, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Candida albicans, Microbial Sensitivity Tests, Fluconazole, Biofilms, Drug Resistance, Fungal, Glucan 1,3-beta-Glucosidase, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.